BioSpace

Biogen set up for growth even without M&A but CEO won’t rule it out

Biogen is growing as planned, with marketed products generating more revenue and multiple late-stage readouts expected over the next year. Building out an early-stage pipeline would be a bonus, CEO Chris Viehbacher said on a Q3 earnings call Wednesday.

By BioSpace

1 min read
Biogen set up for growth even without M&A but CEO won’t rule it out
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights